gabapentin has been researched along with Myoclonic Jerk in 24 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 7.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 3.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "To report on the occurrence of myoclonus in patients receiving gabapentin (GBP) for the treatment of epilepsy." | 3.70 | Myoclonus associated with the use of gabapentin. ( Asconapé, J; DellaBadia, J; Diedrich, A, 2000) |
| "We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact." | 3.69 | Movement disorders associated with the use of gabapentin. ( Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL, 1996) |
| "In the other cases, myoclonus was only subtle and did not significantly interfere with daily activities, so that a dose reduction of PGB was not considered necessary." | 2.70 | Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. ( Feuerstein, TJ; Huppertz, HJ; Schulze-Bonhage, A, 2001) |
| "However, PGB or GBP induced myoclonus has only been reported infrequently in case reports/series." | 2.61 | Gabapentin or pregabalin induced myoclonus: A case series and literature review. ( Desai, A; Kherallah, Y; Marawar, R; Szabo, C, 2019) |
| "Negative myoclonus is a jerky, brief, and sudden interruption of voluntary muscle contraction." | 2.55 | Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review. ( Jung, JM; Kim, JB; Kwon, DY; Lee, EJ; Park, MH, 2017) |
| "The diagnosis of myoclonus was more difficult than those of epilepsy, because the clarification of pathogenesis and definition of diagnosis was lacked." | 2.38 | [Diagnosis and therapy of epilepsy and myoclonus]. ( Okamoto, Y; Ota, K, 1993) |
| " With 2-L exchanges every 2 hours, we document an apparent elimination half-life of 41." | 1.46 | Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance. ( Edwards, JC; Ibrahim, H; Oman, Z; Schuelke, M, 2017) |
| "Acquired pendular nystagmus (APN) occurs with multiple sclerosis (MS) and oculopalatal tremor (OPT); distinct features of the nystagmus have led to the development of separate models for their pathogenesis." | 1.37 | Pharmacological tests of hypotheses for acquired pendular nystagmus. ( Leigh, RJ; Optican, LM; Shaikh, AG; Thurtell, MJ, 2011) |
| "We found 3 cases (1." | 1.35 | [Development or worsening of myoclonus associated with gabapentin therapy]. ( Ikeda, H; Inoue, Y; Koide, Y, 2009) |
| "Lingual myoclonus is a poorly understood disorder that may occur in isolation or combined with palatal myoclonus." | 1.34 | New device to control combined lingual and palatal myoclonus. ( Boon, AJ; de Gier, HH; Mondria, T, 2007) |
| "Acquired generalized repetitive myoclonus may be mistaken for tremor." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "Three of 71 patients had myoclonus with GBP doses ranging from 9 mg/kg to 20 mg/kg and within 4 months of treatment onset." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "Gabapentin dose-dependently attenuated myoclonus in posthypoxic rats for more than 3 h." | 1.29 | Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. ( Kanthasamy, AG; Truong, DD; Vu, TQ; Yun, RJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, H | 1 |
| Oman, Z | 1 |
| Schuelke, M | 1 |
| Edwards, JC | 1 |
| Kim, JB | 1 |
| Jung, JM | 1 |
| Park, MH | 1 |
| Lee, EJ | 1 |
| Kwon, DY | 1 |
| Desai, A | 1 |
| Kherallah, Y | 1 |
| Szabo, C | 1 |
| Marawar, R | 1 |
| Hui, CH | 1 |
| Leung, JK | 1 |
| Chang, RS | 2 |
| Shea, YF | 2 |
| Mok, MM | 1 |
| Ege, F | 1 |
| Koçak, Y | 1 |
| Titiz, AP | 1 |
| Oztürk, SM | 1 |
| Oztürk, S | 1 |
| Ozbakir, S | 1 |
| Pierce, DA | 1 |
| Holt, SR | 1 |
| Reeves-Daniel, A | 1 |
| Koide, Y | 1 |
| Ikeda, H | 1 |
| Inoue, Y | 1 |
| Healy, DG | 1 |
| Ingle, GT | 1 |
| Brown, P | 1 |
| Lucey, BP | 1 |
| Noetzel, MJ | 1 |
| Duntley, SP | 1 |
| Prieto-Pérez, L | 1 |
| Montastruc, J | 1 |
| García-Ruiz, PJ | 1 |
| Shaikh, AG | 1 |
| Thurtell, MJ | 1 |
| Optican, LM | 1 |
| Leigh, RJ | 1 |
| Gazulla Abío, J | 1 |
| Feijóo de Freixo, M | 1 |
| Val Adán, P | 1 |
| Benavente Aguilar, I | 1 |
| Scullin, P | 1 |
| Sheahan, P | 1 |
| Sheila, K | 1 |
| Zhang, C | 1 |
| Glenn, DG | 1 |
| Bell, WL | 1 |
| O'Donovan, CA | 1 |
| Holtkamp, M | 1 |
| Halle, A | 1 |
| Meierkord, H | 1 |
| Masuhr, F | 1 |
| Mondria, T | 1 |
| de Gier, HH | 1 |
| Boon, AJ | 1 |
| McKeon, A | 1 |
| Pittock, SJ | 1 |
| Glass, GA | 1 |
| Josephs, KA | 1 |
| Bower, JH | 1 |
| Lennon, VA | 1 |
| Ahlskog, JE | 1 |
| Okamoto, Y | 1 |
| Ota, K | 1 |
| Kanthasamy, AG | 1 |
| Vu, TQ | 1 |
| Yun, RJ | 1 |
| Truong, DD | 1 |
| Reeves, AL | 1 |
| So, EL | 1 |
| Sharbrough, FW | 1 |
| Krahn, LE | 1 |
| Asconapé, J | 1 |
| Diedrich, A | 1 |
| DellaBadia, J | 1 |
| Mercadante, S | 1 |
| Villari, P | 1 |
| Fulfaro, F | 1 |
| Huppertz, HJ | 1 |
| Feuerstein, TJ | 1 |
| Schulze-Bonhage, A | 1 |
3 reviews available for gabapentin and Myoclonic Jerk
| Article | Year |
|---|---|
Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review.
Topics: Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma- | 2017 |
Gabapentin or pregabalin induced myoclonus: A case series and literature review.
Topics: Adult; Aged; Analgesics; Chronic Pain; Female; Gabapentin; Humans; Male; Middle Aged; Myoclonus; Pre | 2019 |
[Diagnosis and therapy of epilepsy and myoclonus].
Topics: Acetates; Amines; Cerebral Cortex; Cyclohexanecarboxylic Acids; Electrophysiology; Epilepsy; Gabapen | 1993 |
1 trial available for gabapentin and Myoclonic Jerk
| Article | Year |
|---|---|
Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Dos | 2001 |
20 other studies available for gabapentin and Myoclonic Jerk
| Article | Year |
|---|---|
Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Nephropathies; Diabetic Neuropathies; Fema | 2017 |
Reversible dysphagia due to gabapentin-induced jaw myoclonus.
Topics: Aged, 80 and over; Female; Gabapentin; Humans; Jaw; Myoclonus | 2019 |
Gabapentin-induced myoclonus in an elderly with end-stage renal failure.
Topics: Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobuty | 2014 |
Gabapentin-Induced myoclonus: case report.
Topics: Aged, 80 and over; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Amin | 2008 |
A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
Topics: Acute Kidney Injury; Amines; Anticonvulsants; Anuria; Comorbidity; Cyclohexanecarboxylic Acids; Diab | 2008 |
[Development or worsening of myoclonus associated with gabapentin therapy].
Topics: Adult; Amines; Anticonvulsants; Contraindications; Cyclohexanecarboxylic Acids; Epilepsy, Tonic-Clon | 2009 |
Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; K | 2009 |
Paroxysmal arousals and myoclonic movements associated with interictal epileptiform discharges in NREM and REM sleep.
Topics: Adolescent; Amines; Antiparkinson Agents; Arousal; Chromosome Disorders; Chromosome Inversion; Chrom | 2011 |
[Myoclonias secondary to gabapentin in a patient with chronic renal failure].
Topics: Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failu | 2011 |
Pharmacological tests of hypotheses for acquired pendular nystagmus.
Topics: Amines; Baclofen; Cerebellar Cortex; Cyclohexanecarboxylic Acids; Eye Movements; Gabapentin; gamma-A | 2011 |
[Clinical and neurochemical aspects of diaphragmatic myoclonus].
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Diaphragm; Female; GABA Agoni | 2003 |
Myoclonic jerks associated with gabapentin.
Topics: Acetates; Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobut | 2003 |
Gabapentin-induced myoclonus in end-stage renal disease.
Topics: Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric | 2005 |
Gabapentin-induced severe myoclonus in a patient with impaired renal function.
Topics: Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Disea | 2006 |
New device to control combined lingual and palatal myoclonus.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Clonazepam; Cyclohexanecarboxylic Acids; Eye Movement | 2007 |
Whole-body tremulousness: isolated generalized polymyoclonus.
Topics: Adult; Aged; Amines; Anticonvulsants; Autoimmunity; Breast Neoplasms; Clonazepam; Cyclohexanecarboxy | 2007 |
Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus.
Topics: Acetates; Acoustic Stimulation; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; DDT; | 1996 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, | 1996 |
Myoclonus associated with the use of gabapentin.
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dose-Response Rel | 2000 |
Gabapentin for opiod-related myoclonus in cancer patients.
Topics: Acetates; Amines; Analgesics, Opioid; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamm | 2001 |